Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J. Hutton, MD, Michael K Racke, MD, Uday R. Popat, M.D., Steven M. Devine, MD, George E. Georges, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Meagan Spychala, Noha Lim, PhD, Sachin Malhotra, PhD, Deborah Phippard, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2012) 120 (21): 962.

https://doi.org/10.1182/blood.V120.21.962.962

Published: 2012

Journal Articles

Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis

Jan Storek, MD, PhD, Rob Woolson, MS, Paul K. Wallace, MS, PhD, Gregory Sempowski, MD, Peter A. McSweeney, MD, Maureen Mayes, MD, Leslie Crofford, MD, Sharon LeClercq, MD, Richard A. Nash, MD, Keith M. Sullivan, MD

Blood (2011) 118 (21): 4917.

https://doi.org/10.1182/blood.V118.21.4917.4917

Published: 2011

Journal Articles

Peripheral Blood Stem Cell Mobilization with Single Agent Plerixafor Induces FoxP3 Expression in Donor T Cells and Enables Durable Long Term Hematopoietic Engraftment Across Mismatched Major Histocompatibility Complex Barriers

Brian Kornblit, MD, PhD, Billanna Hwang, Barry Storer, PhD, Monica S Thakar, MD, Erlinda B Santos, Richard A. Nash, MD, Brenda M. Sandmaier, MD

Blood (2011) 118 (21): 1891.

https://doi.org/10.1182/blood.V118.21.1891.1891

Published: 2011

Journal Articles

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Richard A. Nash, MD, George J Hutton, MD, Michael K Racke, MD, Uday R Popat, MD, Steven M. Devine, MD, Linda M. Griffith, MD, PhD, Paolo A Muraro, MD, Harry Openshaw, MD, Peter H. Sayre, MD, PhD, Olaf Stuve, MD, Douglas L Arnold, MD, Lisa Wruck, PhD, Annette Wundes, MD, George H Kraft, MD, James D Bowen, MD

Blood (2011) 118 (21): 3075.

https://doi.org/10.1182/blood.V118.21.3075.3075

Published: 2011

Journal Articles

Prognostic Factors and Outcomes of Severe Gastrointestinal Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Cristina Castilla-LLorente, MD., PHD., Richard A. Nash, MD, George B McDonald, Barry E. Storer, PhD, Paul J. Martin, MD

Blood (2008) 112 (11): 4341.

https://doi.org/10.1182/blood.V112.11.4341.4341

Published: 2008

Journal Articles

In Vivo Modulation of T Cell and Monocyte Function Following Infusion of Mesenchymal Stromal Cells (MSC)

Cristina Castilla-LLorente, MD., PHD., Mineo Iwata, Marco Mielcarek, MD, PhD, V. Kraig Abrams, BS., Billanna Hwang, BS, Richard A. Nash, MD, Beverly Torok-Storb, PhD

Blood (2008) 112 (11): 4739.

https://doi.org/10.1182/blood.V112.11.4739.4739

Published: 2008

Journal Articles

Ex Vivo Expanded T Regulatory (Treg) Cells Block Conversion of Mixed Chimeras To Complete Donor Chimerism.

Marina Lesnikova, PhD, Alla Nikitine, MD, Nicola Mason, D.V.M, Richard A. Nash, MD, George E. Georges, MD

Blood (2006) 108 (11): 5168.

https://doi.org/10.1182/blood.V108.11.5168.5168

Published: 2006

Journal Articles

Peripheral CD4 + CD25 + Regulatory T Cells (T reg ) Block Alloreactive Host Anti-Donor T Cells in Canine Mixed Hematopoietic Chimeras.

Marina Lesnikova, PhD, Alla Nikitine, MD, Lina Pogosov, Richard A. Nash, MD, George E. Georges, MD

Blood (2005) 106 (11): 3101.

https://doi.org/10.1182/blood.V106.11.3101.3101

Published: 2005

Journal Articles

Ex Vivo Expansion of Canine CD4 + CD25 + Regulatory T Cells (T reg ) with Artificial Antigen Presenting Cells (aAPC).

Marina Lesnikova, PhD, Alla Nikitine, MD, Lina Pogosov, Nicola Mason, DVM, Richard A. Nash, MD, George E. Georges, MD

Blood (2005) 106 (11): 3102.

https://doi.org/10.1182/blood.V106.11.3102.3102

Published: 2005

NARROW

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Low Blood Counts of Memory/Effector CD8 T Cells, Gamma/Delta T Cells, Memory B Cells and Plasmacytoid Dendritic Cells and High Counts of Th2 Cells in Systemic Sclerosis

Peripheral Blood Stem Cell Mobilization with Single Agent Plerixafor Induces FoxP3 Expression in Donor T Cells and Enables Durable Long Term Hematopoietic Engraftment Across Mismatched Major Histocompatibility Complex Barriers

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: Early Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

Prognostic Factors and Outcomes of Severe Gastrointestinal Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

In Vivo Modulation of T Cell and Monocyte Function Following Infusion of Mesenchymal Stromal Cells (MSC)

Ex Vivo Expanded T Regulatory (Treg) Cells Block Conversion of Mixed Chimeras To Complete Donor Chimerism.

Peripheral CD4 + CD25 + Regulatory T Cells (T reg ) Block Alloreactive Host Anti-Donor T Cells in Canine Mixed Hematopoietic Chimeras.

Ex Vivo Expansion of Canine CD4 + CD25 + Regulatory T Cells (T reg ) with Artificial Antigen Presenting Cells (aAPC).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only